Trial intelligence / Profile preview

Preoperative Osmotic Laxatives in Robotic Urologic Surgery

NCT05805436Phase 4Recruiting

Start
Jun 2023
Primary completion
Mar 2026
Modality
Injectable Hydrogels, Implantable Hydrogels, Biodegradable Polymers
Countries
1
01

Overview

Phase 4, randomised, open-label trial of polyethylene glycol 3350 in constipation (2 arms). Primary endpoint: Time to first bowel movement after surgery at 7 days. Started Jun 2023; status: recruiting.

02

Drugs

polyethylene glycol 3350
03

Conditions

constipation

Beyond the preview

Go deeper on NCT05805436.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05805436.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call